Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction - GUSTO V randomized trial / Lincoff, Am; Califf, Rm; Van de Werf, F; Willerson, Jt; White, Hd; Armstrong, Pw; Guetta, V; Gibler, Wb; Hochman, Js; Bode, C; Vahanian, A; Steg, Pg; Ardissino, D; Savonitto, S; Bar, F; Sadowski, Z; Betriu, A; Booth, Je; Wolski, K; Waller, M; Topol, Ej. - In: JAMA. - ISSN 0098-7484. - 288:17(2002), pp. 2130-2135. [10.1001/jama.288.17.2130]

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction - GUSTO V randomized trial

Ardissino D;
2002-01-01

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction - GUSTO V randomized trial / Lincoff, Am; Califf, Rm; Van de Werf, F; Willerson, Jt; White, Hd; Armstrong, Pw; Guetta, V; Gibler, Wb; Hochman, Js; Bode, C; Vahanian, A; Steg, Pg; Ardissino, D; Savonitto, S; Bar, F; Sadowski, Z; Betriu, A; Booth, Je; Wolski, K; Waller, M; Topol, Ej. - In: JAMA. - ISSN 0098-7484. - 288:17(2002), pp. 2130-2135. [10.1001/jama.288.17.2130]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2883547
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 90
social impact